Argatroban attenuates leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia
- PMID: 12869718
- DOI: 10.1161/01.STR.0000083052.01361.3D
Argatroban attenuates leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia
Abstract
Background and purpose: Argatroban, a direct thrombin inhibitor, has been shown to reduce neural injury after transient cerebral ischemia. It has also been reported that this neuroprotective effect results from an anticoagulant function. This study was designed to evaluate quantitatively the inhibitory effects of argatroban on leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia.
Methods: Retinal ischemia was induced for 60 minutes in male Long-Evans rats by temporary ligation of the optic sheath (n=342). Argatroban was administered just after induction of ischemia. Leukocyte and platelet behavior in the retinal microcirculation was then evaluated in vivo with scanning laser ophthalmoscopy. The expression of P-selectin and intracellular adhesion molecule-1 (ICAM-1) was evaluated by reverse transcription-polymerase chain reaction. After 10 days of reperfusion, ischemia-induced retinal damage was evaluated histologically.
Results: Treatment with argatroban suppressed leukocyte-endothelial cell interactions; the maximum numbers of rolling and accumulated leukocytes were reduced by 90.1% (P<0.05) and 58.7% (P<0.05), respectively, at 12 hours after reperfusion. Treatment with argatroban also suppressed platelet-endothelial cell interactions; the maximum numbers of rolling and adhering platelets were reduced by 91.8% (P<0.01) and 78.9% (P<0.01), respectively, at 12 hours after reperfusion. The expression of P-selectin and ICAM-1 mRNA was suppressed significantly in the argatroban-treated retinas (P<0.01). Histologic examination demonstrated the protective effect of argatroban on ischemia-induced retinal damage (P<0.01).
Conclusions: Argatroban treatment suppressed leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia. This inhibitory effect on postischemic blood cell-endothelial cell interactions might partially contribute to its neuroprotective effects.
Similar articles
-
Thrombin inhibitor reduces leukocyte-endothelial cell interactions and vascular leakage after scatter laser photocoagulation.Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2561-6. doi: 10.1167/iovs.04-1102. Invest Ophthalmol Vis Sci. 2005. PMID: 15980248
-
Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury.Invest Ophthalmol Vis Sci. 2003 Jan;44(1):332-41. doi: 10.1167/iovs.02-0493. Invest Ophthalmol Vis Sci. 2003. PMID: 12506093
-
Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte-endothelial cell interactions.J Thromb Haemost. 2007 Apr;5(4):818-25. doi: 10.1111/j.1538-7836.2007.02425.x. J Thromb Haemost. 2007. PMID: 17408412
-
[In vivo evaluation of leukocyte dynamics in the retinal and choroidal circulation].Nippon Ganka Gakkai Zasshi. 1999 Dec;103(12):910-22. Nippon Ganka Gakkai Zasshi. 1999. PMID: 10643293 Review. Japanese.
-
Adhesion molecule expression in postischemic microvascular dysfunction: activity of a micronized purified flavonoid fraction.J Vasc Res. 1999;36 Suppl 1:15-23. doi: 10.1159/000054070. J Vasc Res. 1999. PMID: 10474047 Review.
Cited by
-
The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation.Biomaterials. 2014 Aug;35(26):7271-85. doi: 10.1016/j.biomaterials.2014.05.036. Epub 2014 Jun 10. Biomaterials. 2014. PMID: 24927680 Free PMC article.
-
A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury.Am J Pathol. 2018 Dec;188(12):2717-2728. doi: 10.1016/j.ajpath.2018.08.010. Epub 2018 Sep 18. Am J Pathol. 2018. PMID: 30236476 Free PMC article.
-
In vivo evaluation of ocular inflammatory responses in experimental diabetes.Br J Ophthalmol. 2005 Aug;89(8):1052-7. doi: 10.1136/bjo.2004.061929. Br J Ophthalmol. 2005. PMID: 16024864 Free PMC article.
-
Baicalin attenuates focal cerebral ischemic reperfusion injury by inhibition of protease-activated receptor-1 and apoptosis.Chin J Integr Med. 2014 Feb;20(2):116-22. doi: 10.1007/s11655-013-1441-7. Epub 2013 Mar 16. Chin J Integr Med. 2014. PMID: 23504578
-
Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury.J Neuroinflammation. 2013 Dec 10;10:149. doi: 10.1186/1742-2094-10-149. J Neuroinflammation. 2013. PMID: 24325836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous